ES8205201A1 - Un procedimiento para la preparacion de 4-alquil-sustituido-3--hidroxi-3-pirrolin-2,5 dionas. - Google Patents

Un procedimiento para la preparacion de 4-alquil-sustituido-3--hidroxi-3-pirrolin-2,5 dionas.

Info

Publication number
ES8205201A1
ES8205201A1 ES501077A ES501077A ES8205201A1 ES 8205201 A1 ES8205201 A1 ES 8205201A1 ES 501077 A ES501077 A ES 501077A ES 501077 A ES501077 A ES 501077A ES 8205201 A1 ES8205201 A1 ES 8205201A1
Authority
ES
Spain
Prior art keywords
alkylsubstituted
pyrroline
hydroxy
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES501077A
Other languages
English (en)
Other versions
ES501077A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES8205201A1 publication Critical patent/ES8205201A1/es
Publication of ES501077A0 publication Critical patent/ES501077A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • C07D207/444Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
    • C07D207/456Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE 4-ALQUIL-SUSTITUIDO-3-HIDROXI-3-PIRROLIN-2,5-DIONAS Y DE SUS SALES FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE R ES ALQUILO C6-16. CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA RCH2CN, EN LA QUE R ES EL MISMO QUE EN LA FORMULA (I), CON AXALATO DE DIETILO, EN UN DISOLVENTE ORGANICO INERTE, EN PRESENCIA DE UNA BASE, TAL COMO T-BUTOXIDO POTASICO, A UNA TEMPERATURA ENTRE LA AMBIENTE Y 60 GRADOS CENTIGRADOS, SEGUIDA DE LA HIDROLISIS CATALIZADA POR ACIDOS Y REACCION DE CICLACION POR CALENTAMIENTO PROLONGADO A 60 GRADOS CENTIGRADOS.
ES501077A 1980-04-04 1981-04-03 Un procedimiento para la preparacion de 4-alquil-sustituido-3--hidroxi-3-pirrolin-2,5 dionas. Granted ES501077A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/137,345 US4428959A (en) 1980-04-04 1980-04-04 4-Alkylsubstituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase

Publications (2)

Publication Number Publication Date
ES8205201A1 true ES8205201A1 (es) 1982-06-01
ES501077A0 ES501077A0 (es) 1982-06-01

Family

ID=22476981

Family Applications (1)

Application Number Title Priority Date Filing Date
ES501077A Granted ES501077A0 (es) 1980-04-04 1981-04-03 Un procedimiento para la preparacion de 4-alquil-sustituido-3--hidroxi-3-pirrolin-2,5 dionas.

Country Status (8)

Country Link
US (1) US4428959A (es)
EP (1) EP0037991B1 (es)
JP (1) JPS56154459A (es)
DE (1) DE3160632D1 (es)
DK (1) DK153181A (es)
ES (1) ES501077A0 (es)
GR (1) GR74130B (es)
PT (1) PT72772B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US6903105B2 (en) * 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US20050090505A1 (en) * 2003-08-18 2005-04-28 Johnson Michael R. Methods of reducing risk of infection from pathogens
US7745442B2 (en) * 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
US20090253714A1 (en) * 2003-08-20 2009-10-08 Johnson Michael R Methods of reducing risk of infection from pathogens
US20070021439A1 (en) * 2005-07-25 2007-01-25 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
JP6392241B2 (ja) 2012-12-17 2018-09-19 パリオン・サイエンシィズ・インコーポレーテッド 3,5−ジアミノ−6−クロロ−n−(n−(4−フェニルブチル)カルバムイミドイル)ピラジン−2−カルボキサミド化合物
DK2931713T3 (en) 2012-12-17 2017-01-30 Parion Sciences Inc CHLORPYRAZINE CARBOXAMIDE DERIVATIVES USED FOR THE TREATMENT OF DISEASES BENEFITED BY INDEPENDENT MOSPHEREWIN
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
US10562844B2 (en) 2015-01-26 2020-02-18 Wake Forest University Health Sciences HYPDH inhibitors and methods of use for the treatment of kidney stones

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340263A (en) * 1964-02-14 1967-09-05 Ciba Geigy Corp Amino-pyrroles
US4256758A (en) * 1979-06-11 1981-03-17 Merck & Co., Inc. 4-Substituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase

Also Published As

Publication number Publication date
EP0037991A1 (en) 1981-10-21
US4428959A (en) 1984-01-31
PT72772B (en) 1983-02-08
DK153181A (da) 1981-10-05
DE3160632D1 (en) 1983-08-25
PT72772A (en) 1981-04-01
ES501077A0 (es) 1982-06-01
EP0037991B1 (en) 1983-07-20
JPS56154459A (en) 1981-11-30
GR74130B (es) 1984-06-06

Similar Documents

Publication Publication Date Title
ES8105283A1 (es) Un procedimiento para la preparacion de nuevas 3-hidroxi-3- pirrolin-2, 5-dionas-4-sustituidas
ES8105996A1 (es) Un procedimiento para la preparacion de 4-(tiazolil sustituido)-3-hidroxi-3-pinrolin 2,5.dionas inhibodoras de la acido glicolico oxidasa.
ES8300758A1 (es) Un procedimiento para la preparacion de nuevos pirazimil-1,2,4 oxadiazol-5-onas.
EP0328251A3 (en) 2-(2-hydroxy-3-phenoxypropylamino)ethylphenoxyacetamides and processes and intermediates for their preparation
GR3019388T3 (en) The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse
ES8205201A1 (es) Un procedimiento para la preparacion de 4-alquil-sustituido-3--hidroxi-3-pirrolin-2,5 dionas.
ES8506658A1 (es) Procedimiento para la preparacion de 3-(1-sustituido-4-piperidil)-1, 2-bencisoxazoles
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
ATE85523T1 (de) Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen.
DE69521536D1 (de) Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten
FR2441627A1 (fr) Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant
MW2789A1 (en) Novel furan polyols,use thereof as polyols in the formation of polyurethanes,polyurenthanes thus obtained and process for preparing same
DE3374005D1 (en) 1-methyl-5-nitro-imidazoline derivatives and therapeutic compositions which contain them as active principle
AU8452791A (en) 1-phenyl-3-aryl-2-propyne-1-ones
AU578952B2 (en) Novel pharmaceutical compositions having immuno-suppressive properties
DE3468870D1 (en) Antihypertensive 3-aryl-1,2-benzisoxazolsulfonyl and-sulfinyl-alkanoic acids, a process for their preparation and their use for the preparation of medicaments
ATE95062T1 (de) Zusammensetzung zur behandlung von krebs, gekennzeichnet durch ueberexpression des c-fmsproto-onkogens.
ES402468A1 (es) Un procedimiento para la preparacion de vincamina y compuestos semejantes
DE3887005D1 (de) Mittel zur Behandlung von Nierenbeschwerden.
RU93055683A (ru) Ингибиторы вич-протеазы, способ их получения, их использование, композиция
ZA879632B (en) Novel furan polyols,use thereof as polyols in the formation of polyurethanes,polyurethanes thus obtained and process for preparing same
RU93055681A (ru) Ингибиторы вич-протеазы, способ их получения, их использование в фармкомпозициях